Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details)

v3.23.1
Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details) - shares
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 147,707 43,996
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 1,974,828 693,717
Non-vested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 1,274,603  
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 240,100 240,100